Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jan;3(1):22-9.
doi: 10.1007/s11882-003-0006-9.

Immunopharmacology of hypersensitivity reactions to drugs

Affiliations
Review

Immunopharmacology of hypersensitivity reactions to drugs

Dean J Naisbitt et al. Curr Allergy Asthma Rep. 2003 Jan.

Abstract

Drug hypersensitivity reactions are characterized by their unpredictability, lack of simple dose-dependency, host sensitivity, and potentially serious clinical outcome. They occur in a small proportion of patients, and usually the predisposing factors are unknown, although there is increasing evidence for genetic predisposition and disease being significant risk factors. The current understanding of the chemical basis of immune-mediated reactions is based on the hapten hypothesis, which requires drug bioactivation, covalent binding to proteins, followed by uptake, antigen processing, and a polyclonal immune response. The recently proposed "danger hypothesis" can be considered to be an essential addition to the hapten hypothesis. According to the danger hypothesis, the immune response to a drug-derived antigen requires the presence of co-stimulatory signals and cytokines, which propagate and determine the type of immune response. The "danger signal" might result from chemical, physical, or viral stress.

PubMed Disclaimer

References

    1. Mol Pharmacol. 2002 Sep;62(3):628-37 - PubMed
    1. J Immunol. 1999 Mar 15;162(6):3256-62 - PubMed
    1. Lancet. 2000 Nov 4;356(9241):1587-91 - PubMed
    1. Drug Metab Dispos. 1996 Apr;24(4):469-79 - PubMed
    1. J Invest Dermatol. 2000 Jun;114(6):1164-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources